Dr. Kunchok is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Sydney Faculty of MedicineClass of 2010
Certifications & Licensure
OH State Medical License 2020 - 2026
MN State Medical License 2018 - 2020
Publications & Presentations
PubMed
- : Welcoming a New Member of theFamily of Journals.Amy C Kunchok, Morgan S Sorenson, Patricia K Baskin, José G Merino
Neurology. 2025-02-11 - Episodic aphasia following a motor vehicle collision.Albert Aboseif, Emily F Maly, Faez H Syed, Vineet Punia, Amy Kunchok
Practical Neurology. 2025-01-16 - Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors.Saira Afzal, Yadi Li, Brittany Lapin, Le H Hua, Lucy Boyce Kennedy
Annals of Clinical and Translational Neurology. 2024-12-31
Journal Articles
- Opsoclonus in Anti-Ma2 Brain-Stem EncephalitisAmy Kunchok, Andrew Mckeon, The New England Journal of Medicine
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAmy Kunchok, Brian G Weinshenker, Eoin P Flanagan, Sean J Pittock, JAMA Neurology
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsAmy Kunchok, Allen J Aksamit, Sean J Pittock, Brian G Weinshenker, Andrew Mckeon, JAMA Neurology
Authored Content
- Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients with Myelin Oligodendrocyte Glycoprotein IgG–Associated DisordersAugust 2020
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsMay 2020
Press Mentions
Mark Your Calendar for TSF's Cleveland Patient DayMay 24th, 2024- Oncology Pharmacovigilance Clinic Expands SpecialtiesMay 2nd, 2024
- Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World StudyApril 17th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
